Safety and Efficacy of Talampanel in Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00267592
Recruitment Status : Completed
First Posted : December 21, 2005
Last Update Posted : May 19, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2008
  Actual Study Completion Date : February 2011
  Certification/Extension First Submitted : August 16, 2011